U.S. markets closed
  • S&P 500

    4,411.79
    +44.31 (+1.01%)
     
  • Dow 30

    35,061.55
    +238.20 (+0.68%)
     
  • Nasdaq

    14,836.99
    +152.39 (+1.04%)
     
  • Russell 2000

    2,209.65
    +10.17 (+0.46%)
     
  • Crude Oil

    72.17
    +0.26 (+0.36%)
     
  • Gold

    1,802.10
    -3.30 (-0.18%)
     
  • Silver

    25.24
    -0.14 (-0.56%)
     
  • EUR/USD

    1.1770
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.2860
    +0.0210 (+1.66%)
     
  • GBP/USD

    1.3754
    -0.0013 (-0.10%)
     
  • USD/JPY

    110.5100
    +0.3950 (+0.36%)
     
  • BTC-USD

    34,200.91
    +2,066.49 (+6.43%)
     
  • CMC Crypto 200

    786.33
    -7.40 (-0.93%)
     
  • FTSE 100

    7,027.58
    +59.28 (+0.85%)
     
  • Nikkei 225

    27,548.00
    +159.80 (+0.58%)
     

Top Ranked Momentum Stocks to Buy for March 5th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 5th:

Sangamo Therapeutics, Inc. (SGMO): This biotechnology company that focuses on translating science into genomic medicines has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.2% over the last 60 days.

Sangamo Therapeutics, Inc. Price and Consensus

Sangamo Therapeutics, Inc. Price and Consensus
Sangamo Therapeutics, Inc. Price and Consensus

Sangamo Therapeutics, Inc. price-consensus-chart | Sangamo Therapeutics, Inc. Quote

Sangamo Therapeutics’ shares gained 6.3% over the last one month against the S&P 500’s decline of 6.1%. The company possesses a Momentum Score of A.

Sangamo Therapeutics, Inc. Price

Sangamo Therapeutics, Inc. Price
Sangamo Therapeutics, Inc. Price

Sangamo Therapeutics, Inc. price | Sangamo Therapeutics, Inc. Quote

Stamps.com Inc. (STMP): This company that provides Internet-based mailing and shipping solutions has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.2% over the last 60 days.

Stamps.com Inc. Price and Consensus

Stamps.com Inc. Price and Consensus
Stamps.com Inc. Price and Consensus

Stamps.com Inc. price-consensus-chart | Stamps.com Inc. Quote

Stamps.com shares gained 634% over the last one month. The company possesses a Momentum Score of B.

Stamps.com Inc. Price

Stamps.com Inc. Price
Stamps.com Inc. Price

Stamps.com Inc. price | Stamps.com Inc. Quote

Enphase Energy, Inc. (ENPH): This company that designs, develops, and sells home energy solutions for the solar photovoltaic industry has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.7% over the last 60 days.

Enphase Energy, Inc. Price and Consensus

Enphase Energy, Inc. Price and Consensus
Enphase Energy, Inc. Price and Consensus

Enphase Energy, Inc. price-consensus-chart | Enphase Energy, Inc. Quote

Enphase Energy’s shares gained 44.9% over the last one month. The company possesses a Momentum Score of B.

Enphase Energy, Inc. Price

Enphase Energy, Inc. Price
Enphase Energy, Inc. Price

Enphase Energy, Inc. price | Enphase Energy, Inc. Quote

The Rubicon Project, Inc. (RUBI): This company that provides technology solutions to automate the purchase and sale of digital advertising inventory for buyers and sellers has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

The Rubicon Project, Inc. Price and Consensus

The Rubicon Project, Inc. Price and Consensus
The Rubicon Project, Inc. Price and Consensus

The Rubicon Project, Inc. price-consensus-chart | The Rubicon Project, Inc. Quote

The Rubicon Project’s shares gained 8.6% over the last one month. The company possesses a Momentum Score of A.

The Rubicon Project, Inc. Price

The Rubicon Project, Inc. Price
The Rubicon Project, Inc. Price

The Rubicon Project, Inc. price | The Rubicon Project, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Free: Zacks’ Single Best Stock Set to Double

Today you are invited to download our latest Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.

This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.

See 5 Stocks Set to Double>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
The Rubicon Project, Inc. (RUBI) : Free Stock Analysis Report
 
Enphase Energy, Inc. (ENPH) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research